Page last updated: 2024-08-23

pergolide and Adenoma, Prolactin-Secreting, Pituitary

pergolide has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (6.25)	18.7374
1990's	4 (25.00)	18.2507
2000's	9 (56.25)	29.6817
2010's	1 (6.25)	24.3611
2020's	1 (6.25)	2.80

Authors

Authors	Studies
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R	1
Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R	1
Chuman, H; Cornblath, WT; Gebarski, SS; Trobe, JD	1
Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P	1
Abs, R; Verhelst, J	1
Chiarelli, F; Galluzzi, F; La Cauza, F; Salti, R; Stagi, S	1
Molitch, ME	1
Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML	1
Blackard, WG	1
Barkan, AL; Chandler, WF	1
Arita, N; Hanafusa, T; Hayakawa, T; Kamada, Y; Kawarada, Y; Matsuzawa, Y; Miyagawa, J; Nakajima, H; Namba, M; Saitoh, Y; Sugiyama, T; Yamamoto, K	1
Andreadis, CI; Bruce, JN; Freda, PU; Jacobs, TP; Khandji, AG; Khoury, M; Wardlaw, SL	1
Barkan, AL; Chandler, WF; Orrego, JJ	1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R	1
Berezin, M; Findler, G; Gutman, I; Horowitz, A; Tadmor, R	1
Jungmann, E; Saeger, W; Schöffling, K; Schumm-Draeger, PM; Steudel, I	1

Reviews

4 review(s) available for pergolide and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. Frontiers in endocrinology, 2021, Volume: 12 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2	2021
Hyperprolactinemia: pathophysiology and management. Treatments in endocrinology, 2003, Volume: 2, Issue:1 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative	2003
Pharmacologic resistance in prolactinoma patients. Pituitary, 2005, Volume: 8, Issue:1 Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2	2005
Dopamine receptor agonists for treating prolactinomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2002

Trials

3 trial(s) available for pergolide and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary, 2002, Volume: 5, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin	2002
Long-term treatment of prolactin-secreting macroadenomas with pergolide. The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:1 Topics: Adolescent; Adult; Aged; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone	2000
Pergolide as primary therapy for macroprolactinomas. Pituitary, 2000, Volume: 3, Issue:4 Topics: Adolescent; Adult; Amenorrhea; Dopamine Agonists; Female; Galactorrhea; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Visual Fields	2000

Other Studies

9 other study(ies) available for pergolide and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas. Pituitary, 2013, Volume: 16, Issue:4 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult	2013
Delayed visual loss following pergolide treatment of a prolactinoma. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2002, Volume: 22, Issue:2 Topics: Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma; Vision Disorders; Visual Fields	2002
Reversible weight gain and prolactin levels--long-term follow-up in childhood. Journal of pediatric endocrinology & metabolism : JPEM, 2005, Volume: 18, Issue:9 Topics: Adolescent; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Weight Gain	2005
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary, 2005, Volume: 8, Issue:1 Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome	2005
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. The American journal of medicine, 1993, Volume: 94, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma	1993
Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report. Neurosurgery, 1998, Volume: 42, Issue:4 Topics: Adult; Dopamine Agonists; Humans; Luminescent Measurements; Magnetic Resonance Imaging; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma	1998
A case with prolactinoma treated with pergolide and its histology. Endocrine journal, 1998, Volume: 45, Issue:4 Topics: Dopamine Agonists; Female; Humans; Microscopy, Electron; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactinoma	1998
Malignant prolactinoma. Acta endocrinologica, 1992, Volume: 127, Issue:5 Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Middle Aged; Orbital Neoplasms; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Influence of pergolide treatment on xenotransplanted human pituitary tumors of prolactinoma. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1989, Volume: 165, Issue:7 Topics: Animals; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pergolide; Pituitary Neoplasms; Prolactinoma; Transplantation, Heterologous	1989